 |
A Drexel University team of engineers, scientists and biologists have developed a carbon nanotube-based device for probing single living cells without damaging them. ...
Multifunctional carbon-nanotube cellular endoscopes
Artist renderings of a nano-needle poking a single cell have become the symbol of nanotechnology, surfacing on covers of magazines and books for about a decade but actual nano-needles able to interrogate small cells without causing cellular damage have not become reality until recently. A Drexel University team of engineers, scientists and biologists have developed a carbon nanotube-based device for probing single living cells without damaging them. This technique will allow experts to identify diseases in their early stage and advance drug discovery.
The research led by Dr. Yury Gogotsi, professor of materials science and engineering and director of the A.J. Drexel Nanotechnology Institute (DNI) , and Dr. Gary Friedman, professor of electrical engineering, uses the nanotube-based device, known as a cellular endoscope, to evaluate cells about a thousand times smaller than a human hair. The cellular endoscope interrogates the intracellular environment of living cells, delivers fluorescent quantum dots and analyzes molecules inside a cell without the cell recognizing the needle’s presence.
“Drexel’s W. M. Keck Institute for Attofluidic Probes now manufactures the smallest endoscopes ever created,” Gogotsi said. “Endoscopes provide a potentially transformative technology for studying the fundamentals of single living cells and more broadly, for cell biology.”
Cell biologists usually destroy a large number of cells to extract cellular components and biological molecules needed for identifying diseases and analyzing effects of new drugs, or to achieve a better understanding of how the cell functions. Glass pipettes are widely used to inject material into cells. The pipettes cause too much damage to remain within the cell for a long time and are not designed to report information in the form of optical or electrical signals from within the cell.
“We had an idea for a minimally invasive cellular probe, the tip of which could remain within the cell for a long time while reporting important information in the form of optical and electrical signals and transferring tiny amounts of material to and from the cell. This probe is similar to an endoscope employed by doctors to perform minimally invasive operations inside human patients, only much smaller” said Friedman. “A cellular endoscope reported here is a novel, but conceptually simple device,” said Riju Singhal, a doctoral candidate and author of the article “Multifunctional carbon-nanotube cellular endoscopes” published in the Nature Nanotechnology journal.
“It consists of a single carbon nanotube connected to the tips of larger glass micropipettes that are commonly employed in biological studies, enabling them to become widely used in the near future,” said Singhal.
Dr. Michael Schrlau, research assistant professor in Drexel’s Material Science and Engineering who directs the research laboratory of the W. M. Keck Institute, said, “We’re now building upon the multiple demonstrated functions of cellular endoscopes to help answer elusive cell biological questions. One application of cellular endoscopes being actively pursued is intracellular surface-enhanced Raman spectroscopy with gold-coated endoscopes.”
The Drexel team is funded by the Nanoscale Interdisciplinary Research Team National Science Foundation grant and the W. M. Keck Foundation.
Reference:
Drexel Researchers Create Early Disease Detection and Drug Delivery Device for Single Living Cells// http://www.drexel.edu/news/headlines/drexel-researchers-create-early-disease-detection-and-drug-delivery-device-for-single-living-cells.aspx
MXenes potential applications include sensors, wound healing materials, and drug delivery systems. A recent study explored how different synthesis methods affect the safety and performance of MXenes. By comparing etching conditions and intercalation strategies, researchers discovered that fine-tuning the surface chemistry of MXenes plays a crucial role in improving biocompatibility. These results provide practical guidelines for developing safer MXenes and bring the field one step closer to real biomedical applications.
Exellent news, our joint patent application with Drexel University on highly porous MAX phase precursor for MXene synthesis published. Congratulations and thanks to all team involved!
Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Congratulations to all collaborators with this interesting joint work!
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
